Brief: Chinese Health Authority Renews License For Sensus Healthcare’s SRT-100 For Five More Years
Oct 12 (Reuters) - Sensus Healthcare Inc SRTS.O :
* CHINESE HEALTH AUTHORITY RENEWS LICENSE FOR SENSUS
HEALTHCARE’S
SRT-100™ FOR FIVE MORE YEARS
* SENSUS HEALTHCARE INC - EXPECTS TO RECEIVE CHINESE
MARKETING
AUTHORIZATION FOR ITS SCULPTURA RADIATION ONCOLOGY SYSTEM IN
LATER PART OF 2022
Source text for Eikon: ID:nGNX4CSpg5
Further company coverage: SRTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sensus Healthcare
See all newsBrief: Sensus Healthcare - Enters $15 Million Revolving Credit Facility With City National Bank Of Florida - SEC Filing
Brief: Sensus Healthcare Announces Amicable Resolution Of Commercial Dispute With SkinCure Oncology
Sensus Healthcare Q1 revenue falls 59% on absence of largest customer
Brief: Sensus Healthcare Q1 Net Income USD -2.626 Million
Brief: Sensus Healthcare Files Lawsuit Against Skincure Oncology For Breach Of Contract